To the Editor The randomized clinical trial by Rae Olmsted et al1 on stellate ganglion block for patients with posttraumatic stress disorder (PTSD) may have major treatment implications. In comparing elements of the article with specifications in ClinicalTrials.gov,2 I noted some discrepancies that merit discussion.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Stein MB. Questions on a Randomized Clinical Trial of Stellate Ganglion Block for Patients With Posttraumatic Stress Disorder. JAMA Psychiatry. Published online July 01, 2020. doi:10.1001/jamapsychiatry.2020.1815
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: